Immunoprotein Diagnostic Testing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Published Date : Mar 2021 | No. of Pages : 250 Pages | Category : Healthcare

The global Immunoprotein Diagnostic Testing market size is expected to be worth around US$ 20.3 billion by 2030, according to a new report by Vision Research Reports.

The global Immunoprotein Diagnostic Testing market size was valued at US$ 15.8  billion in 2020 and is anticipated to grow at a CAGR of X% during forecast period 2021 to 2030.

Growth Factors

 This growth can be attributed to the rising incidence of chronic diseases. According to American Heart Association’s 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for immunoprotein diagnostics is expected to rise in order to facilitate rapid diagnosis.

According to WHO, nearly 1.69 million deaths due to lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important to reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved to be highly effective in rapidly detecting chronic diseases.

Technological advancements in the field of immunoprotein diagnostics have led to introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.

Report Highlights

On the basis of test type, immunoglobulin tests held the largest market share in 2020. This is due to the fact that they are commonly used and enables healthcare professionals to gather information about the functioning of a patient’s immune system in autoimmune or infectious diseases. However, immunoglobulin tests are not effective in some cases, for example, during chemotherapy or radiation therapy and in ongoing blood transfusion or vaccinations.

Free light chain diagnostic tests are anticipated to exhibit significant growth over the forecast period. This is due to their ability to help in diagnosis, detection, and monitoring of plasma cell disorders. This type of testing is useful for patients suffering from oligosecretory myeloma, light chain-only multiple myeloma, or nonsecretory myeloma.

Complement system proteins tests are also expected to witness lucrative growth over the forecast period. A complement test facilitates monitoring of patients undergoing treatment for autoimmune disorders, such as rheumatoid arthritis and lupus. This testing method also helps measure how advanced these diseases are by monitoring the activity of complement protein in blood.

On the basis of application, infectious disease testing dominated the market in 2020 owing to the rising prevalence of different types of chronic infectious diseases, such as HIV/AIDS. Rapid diagnosis of infectious diseases in immunoprotein diagnostics has led to growth of this segment. Enzyme-based immunoassays are considered rapid testing techniques for detection of infectious diseases.

Oncology testing also held a significant share in 2020 due to high number of cancer cases throughout the world. Availability of different diagnostic methods, such as Epidermal Growth Factor Receptor (EGFR) testing, help in detection of mutations in EFGR gene, which occurs in patients with non-small cell lung cancer and this helps in treatment planning.

Autoimmune disease testing is another segment expected to exhibit attractive growth in the future due to the growing number of patients suffering from chronic diseases, such as rheumatoid arthritis and lupus. Key players are also engaged in production of immunoprotein tests for patients suffering from chronic autoimmune disorders.

Allergy tests are also anticipated to exhibit high growth over the forecast period due to the rising number of people, including children affected with nasal allergies. Blood tests for allergy search for antibodies in the blood. Symptoms of allergy are often life-threatening; therefore, rapid diagnosis is required to minimize risk.

On the basis of technology, Enzyme-based Immunoassay (EIA) held the largest market share in 2016. It can be used as a diagnostic tool as well as a quality control tool in numerous companies and laboratories. Moreover, majority of the key companies have an extensive portfolio of analyzers with EIA technology. For instance, Human Complement C3 ELISA Kit by Abcam uses this technology for diagnosis. These are some of the factors that can be attributed for the largest market share of EIA.

Chemiluminescence assay is expected to exhibit highest growth over the forecast period due to its high specificity and sensitivity as well as ability to detect antigens in human serum & plasma samples. Chemiluminescence assay is frequently characterized as an important tool for instant diagnosis of various diseases and is ascertained to be more accurate than fluorescence-based detection of labeled probes.

Immunoprotein electrophoresis also held a significant share in the market in 2020 due to the fact that this test allows appropriate analysis of protein levels, that is, it analyzes whether protein levels are increasing or decreasing as a result of chronic disorders, such as, autoimmune or cancer-related diseases. It basically helps in the measurement of different types of immunoglobulins present in a patient’s blood.

North America dominated the market due to well-established healthcare infrastructure in the U.S., which has led to an increase in adoption of immunoprotein diagnostic instruments in laboratories and diagnostic centers. Moreover, high incidence of cancer among the U.S. population also led to the growth of this market.

Europe held a significant share in this market in 2020 due to high prevalence of cancer and diabetes among the European population. Increase in number of government initiatives undertaken in Germany to conduct tests for people suffering from multifactorial and chronic diseases, especially to detect cancer, diabetes, lung, and cardiovascular disease, is one of the factors responsible for the growth in this region.

Key Players

Abbott Laboratories; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A; Enzo Biochem, Inc.; F. Hoffmann-La Roche AG; Thermo Fisher Scientific, Inc.; bioMérieux SA; Abcam Plc.; Siemens Healthcare GmbH; Beckman Coulter; and Ortho Clinical Diagnostics

Market Segmentation

  • Test Type Outlook 

    • Complement System Proteins Diagnostic Tests

    • Free Light Chain Diagnostic Tests

    • Haptoglobin Diagnostic Tests

    • Immunoglobulin Diagnostic Tests

    • Prealbumin Diagnostic Tests

    • C-Reactive Protein (CRP) Diagnostic Tests

  • Application Outlook 

    • Infectious Disease Testing

    • Oncology Testing

    • Endocrine Testing

    • Toxicology Testing

    • Allergy Testing

    • Autoimmune Disease Testing

  • Technology Outlook 

    • Radioimmunoassay

    • Enzyme Based Immunoassay

    • Chemiluminescence Assay

    • Immunofluorescence Assay

    • Immunoturbidity Assay

    • Immunoprotein Electrophoresis

  • Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

The Immunoprotein Diagnostic Testing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Immunoprotein Diagnostic Testing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Immunoprotein Diagnostic Testing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunoprotein Diagnostic Testing market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Immunoprotein Diagnostic Testing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Immunoprotein Diagnostic Testing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Immunoprotein Diagnostic Testing by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Immunoprotein Diagnostic Testing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Immunoprotein Diagnostic Testing market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Immunoprotein Diagnostic Testing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Immunoprotein Diagnostic Testing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Immunoprotein Diagnostic Testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Immunoprotein Diagnostic Testing market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Immunoprotein Diagnostic Testing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Immunoprotein Diagnostic Testing market. These factors have benefited the growth of the global market for Immunoprotein Diagnostic Testing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Immunoprotein Diagnostic Testing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Immunoprotein Diagnostic Testing are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.


Featured Research Reports

  • Featured Research Reports

    Retinal Disorders Treatment Market (By Indication: Macular Degeneration, Diabetic Retinopathy, Diabetic Macular Edema, and Others; By Therapeutic Class; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Dystrophic Epidermolysis Bullosa Treatment Market (By Treatment Type: Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant, Others; By Disease Type: DDEB and RDEB; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Bromelain Market (By Application: Food & Beverages, Healthcare & Pharmaceuticals, Cosmetics, and Other Industries; By Source: Stem and Fruit) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Chronic Idiopathic Constipation Treatment Market (By Drug Class: Serotonin-4 [5-Ht4] Receptor Agonist, Guanylate Cyclase-C Agonist, Laxatives, Stimulants, Others; By Route of Administration: Oral and Rectal; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Hemoglobin Feed Market (By Source: Bovine, Swine, Poultry, Shark, Synthetic, Others; By Application: Industrial and Commercial) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

    Read more...